At the early allergy season, "EGIS-RUS" reminds that innovations help to resist typical triggers of allergy. A new advertising campaign of the antihistamine Suprastinex ® started in April on the air of the largest Russian federal channels. The commercial "Science against allergies" tells a story familiar to 76% of Russians who suffer from various types of seasonal and chronic allergy¹: seasonal pollinosis, allergic rhinitis, allergic conjunctivitis, urticaria.

Levocetirizine (Suprastinex ®) was synthesized with attention to scientific achievements in the field of allergology, immunology and stereochemistry. It was developed using stereoisomer synthesis and isolation technology, which was awarded the Nobel Prize in Chemistry in 2001. A feature of Suprastinex® is the ability of levocetirizine to control the activity of allergens for 24 hours³. It is especially convenient because one tablet is enough per day³ to help reduce the allergic reaction and relieve symptoms. Suprastinex ® practically does not cause drowsiness*, therefore it allows you to plan your usual daily routine.

"Launching the advertising campaign, we wanted to remind patients once again that with the development of science, high-tech technologies for the production of medicines also receive an impetus for improvement. Suprastinex ® is a last–generation drug for the treatment of a wide range of allergic indications, ideally combining antihistamine, antiallergic, anti-inflammatory activity. When creating the video, our attention was focused on the vast scientific experience of pharmaceutical developments to help patients forget about allergies and live a full life," EGIS–RUS LLC notes.

Suprastinex ® is available in two dosage forms: drops (suitable for children from two years old) and tablets (for adults and children over 6 years old).

THERE ARE CONTRAINDICATIONS. IT IS NECESSARY TO CONSULT WITH A SPECIALIST.

¹ Almost 80% of Russians suffer from allergies: https:/iz.ru/1483773/2023-03-16/pochti-80-rossiian-straut-ot-allergii
² MLA style: The Nobel Prize in Chemistry 2001. NobelPrize.org. https://ww.nobelprize.org/prizes/chemistry/2001/summary/
³ Based on Suprastinex® Medical Use Instructions (reg. LSR-008568/10, LP-000225)
* when used in therapeutic doses. Based on Suprastinex® Medical Use Instruction (reg. LSR-008568/10, LP-000225)